In this study, we compared the long-term oncological and functional outcomes of laparoscopic partial nephrectomy (LPN) and robot-assisted laparoscopic partial nephrectomy (RAPN) performed in the treatment of renal tumors. The data of 142 patients (RAPN = 71, LPN = 71) were evaluated. Demographic data, perioperative and postoperative outcomes, long-term (5-year) overall survival (OS) and cancer-specific survival (CSS) rates of the patients were compared between the two groups. A P value of less than 0.05 was considered statistically significant. The mean follow-up time was 61.38 months. There were more complex tumors in the RAPN group (P = 0.014). The duration of warm ischemia time (WIT) was shorter in the RAPN group (P = 0.019).
| INTRODUCTION
Renal cell carcinoma accounts for 2%-3% of all malignant tumors detected in adults and has the highest mortality rate among the urological cancers. 1 The incidence of the disease is increasing with the widespread utilization of ultrasound and other cross-sectional imaging methods. These methods cause an earlier diagnosis of the disease as well as an increase in the incidence of the disease. It is possible to treat these masses which are diagnosed at an earlier stage and limited to the kidney without causing organ loss by partial nephrectomy (PN). Because of the technical and ergonomic difficulties to perform laparoscopy in a reconstructive operation such as PN, laparoscopy is unfortunately not widely accepted in the treatment of these diseases.
LPN is now being performed with highly experienced surgeons and in high case number loaded reference clinics. Robotic surgery has been developed to address this deficit and revolutionized the minimally invasive surgery with the convenience it provides to surgeons.
Robotic surgery has also found widespread application in PN (especially for challenging masses such as hilar and endophytic) and it has been reported that RAPN can be successfully applied after performing approximately about 25 cases. 4 On the other hand, LPN is a technique that requires a considerable number of cases to complete the longlearning curve to achieve optimal experience. Instrumentation with limited motion angles makes it very difficult to excise the tumor, ensure the hemostasis, and repair the collecting system and parenchymal defect in the PN.
The extent to which the convenience RAPN provides for the surgeon reflects on the outcome of the disease is already an important debate. Some authors have reported that RAPN provides a shorter warm ischemia time (WIT) than LPN, as well as similar perioperative results with LPN. 5, 6 The real superiority of RAPN to LPN is controversial in previously completed comparative studies. [5] [6] [7] [8] It is thought that RAPN can improve perioperative and functional outcomes in more complex tumors such as large, hilar, multiple tumors by allowing more competent tumor resection and facilitating reconstructive steps. 9 The functional and oncologic results of RAPN and LPN have been studied by a limited number of studies in the literature. 10, 11 Undoubtedly, the gold standard studies in this area are randomized controlled studies, but ethical issues, patient preferences, and procedure costs render the execution of these studies quite difficult.
In this study, we present a matched pair comparison of patients treated with RAPN and LPN. We aimed to compare the perioperative and long-term functional and oncologic results of RAPN and LPN cases since March 2012, when robotic surgery had been initiated in our clinic. After docking, the colon was medialized and the retroperitoneal area was accessed. The ureter was found. Then, the cleavage was advanced from the ureter to the renal hilus with sharp and blunt dis- 
| MATERIALS AND METHODS

| Patients and measurement methods
| Laparoscopic partial nephrectomy
| Statistical analysis
Propensity score matching was performed for the standardization of the confounding factors in the study group. Multivariate logistic regression was used to calculate the propensity score of each patient according to patient and mass characteristics. A P value of less than 0.05 was considered for statistical significance.
| RESULTS
Each of the RAPN and LPN groups included 71 patients. There were more right-sided tumors in the RAPN group (P = 0.014). Furthermore, the RAPN group included more complex tumors; there were fewer exophytic and more hilar tumors in this group (P = 0.022). Other demographic characteristics were similar between the groups. Demographic data and tumor characteristics of the patients are shown in Table 1 .
The mean WIT in the RAPN group was shorter (P = 0.019). At the postoperative 12th month, new onset stage 3 and 4 renal insufficiencies were observed at the same rates in both groups (4.2% vs 4.2%).
Except these, perioperative and postoperative results were comparable between groups and summarized in Table 2 . The mean follow-up period was 61.38 months (58.11 months for RAPN and 64.82 months for LPN, P = 0.588). There was no significant difference between the two groups in terms of metastasis-free survival, CSS, and OS rates (P = 0.891, P = 0.710, and P = 0.561, respectively) ( Table 3) .
Hypertension, diabetes, and preoperative eGFR were the independent predictive factors for renal insufficiency (P = 0.029, P = 0.013, and P < 0.001, respectively), and preoperative eGFR, WIT, and PSM for 5-year CSS (P = 0.003, P = 0.015, and P = 0.002, respectively) ( Table 4 ).
| DISCUSSION
The wide-angle use capability of the instruments, three-dimensional magnified image, and ergonomic facilities which are provided by the robotic platform have allowed the surgeons to confidently apply nephron-sparing surgery (NSS) to more complex masses and today RAPN has become the preferred operative technique for small, localized renal masses in many centers. 14, 15 In our study, patients who underwent RAPN and LPN had similar demographic characteristics, and we found that those underwent RAPN had a shorter WIT than those underwent LPN. In our study, both methods revealed similar 5-year CSS and OS rates. We have also found that preoperative eGFR is an important predictive factor for both postoperative renal insufficiency and CSS. Baseline eGFR level is an important factor predicting renal insufficiency and CSS after NSS. Likewise, WIT may be a predictive factor as it determines residual kidney quality after surgery. However, the same factors may not be the determining factors for the OS in our cohort. Because, our patient groups were consisted of younger patients and with lower body-mass index than those in the other reports. In this group of patients, other patient-related and environmental factors may come into prominence for the 5-year OS rates. RAPN has been shown to be an important alternative to LPN for NSS. 16 However, with the available data, it is not possible to come to a clear conclusion that the RAPN is superior to LPN. In this regard, especially long-term consequences are limited. There is a strong need for welldesigned studies to compare the important perioperative parameters, such as operation time, estimated blood loss, WIT, length of hospitalization, and analgesic requirement, and postoperative parameters:
long-term functional (creatinine, eGFR) and oncologic outcomes.
Long-term functional outcomes after minimally invasive NSS are an important issue to be addressed. Kim et al. showed that functional outcomes were better and that postoperative renal function recovery was greater in the RAPN group in their 1.032 disease case series. 17 There are conflicting results in the literature about the operation duration of the methods. There are studies showing that RAPN has a shorter operation time, as well as studies showing that there is no significant difference in regards to operation time between the two methods. 3, 18 In our study, mean duration of operation was slightly longer in the RAPN group, but there was no significant difference between the two methods. We believe that the cause of these differences that LPN has been practiced in our clinic for many years but RAPN has been applied for the last 6 years. Experience on the technique of the clinic where the procedure is performed and operating surgical team and available equipment in the operating room are important factors affecting the operation time.
WIT is considered to be an important determinant of postoperative renal function, and the general accepted view is that it should not exceed 20 minutes in NSS. 19 There are a number of studies in the literature that suggest that RAPN provides a shorter WIT than LPN. 5, 18, 20 In these studies, no matching was made between the groups in terms of tumor characteristics by using a nephrometry score. Based on the assumption that RAPN is often reserved for more complex and difficultto-resect tumors, it is possible to say that RAPN provides better perioperative outcomes despite more tumor complexity. In our group, RAPN also provided a shorter WIT in a similar manner. For this reason, we think that RAPN can improve perioperative outcomes.
Important factors predicting postoperative renal insufficiency apart from the applied technique are preoperative eGFR and diseases causing microvessel pathology. 21 In our study, we found that presence of hypertension, diabetes, and preoperative eGFR were independent predictors of postoperative renal insufficiency. We found that the method of operation and WIT had no significant effects. Although RAPN leads to shorter WIT, the less remaining parenchyma due to the presence of more complex tumors in this group may be the likely cause. 26 In our study, the survival rates were slightly lower because the patients had more complications and had a higher mean age. However, in our study, reported that LPN and RAPN provide similar functional outcomes in 381 patients with a RENAL score of at least 7, but that RAPN carries less risk of conversion to radical nephrectomy. 27 There is consensus that both methods are feasible methods for hilar, central, and large complex tumors in experienced hands. 28 However, it should be kept in mind that robotic surgery in these tumors may be able to expand their indications for NSS.
An important handicap of the robotic surgery is the cost problem.
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Of course, it is necessary to apply RAPN independently of cost in difficult tumors, for which the laparoscopic surgery is technically difficult to be applied. However, there is a need to support the results of our study with long-term oncologic and functional outcomes from prospective studies with high-quality data to perform RAPN in broader indications.
Our study has some limitations. First, although most of the cases were performed by a single surgeon, different surgeons performed operations. The experience of the surgeon is an important factor influencing the outcome of an operation. Second, although we have applied propensity score matching to ensure homogeneity of groups, our study is not a prospective randomized study. In addition, some factors that may affect the outcome, such as the surgeon's learning curve and the intraoperative technique used, were not included in the evaluation. The cost of robotic surgery is also an important issue which should be taken into consideration. It would have been better if we had done a cost analysis in our study and compared the groups in this respect. Another shortcoming of our study may be the fact that the groups have a small number of cases. However, we believe that our study will be a significant contributor to the literature because of the limited data on the long-term functional and oncological outcomes of RAPN.
| CONCLUSION
Our study has shown that RAPN provides quite well long-term 
